DK1692097T3 - Tricykliske hydroxamat- og benzamidderivater, sammensætninger og fremgangsmåder - Google Patents
Tricykliske hydroxamat- og benzamidderivater, sammensætninger og fremgangsmåderInfo
- Publication number
- DK1692097T3 DK1692097T3 DK04806498T DK04806498T DK1692097T3 DK 1692097 T3 DK1692097 T3 DK 1692097T3 DK 04806498 T DK04806498 T DK 04806498T DK 04806498 T DK04806498 T DK 04806498T DK 1692097 T3 DK1692097 T3 DK 1692097T3
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- compositions
- methods
- hydroxamate
- tricyclic
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 150000003936 benzamides Chemical class 0.000 title 1
- 102000003964 Histone deacetylase Human genes 0.000 abstract 4
- 108090000353 Histone deacetylase Proteins 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/80—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03293143A EP1541549A1 (en) | 2003-12-12 | 2003-12-12 | Tricyclic hydroxamate and benzaminde derivatives, compositions and methods |
| PCT/IB2004/004334 WO2005058803A1 (en) | 2003-12-12 | 2004-12-10 | Tricyclic hydroxamate and benzamide derivatives, compositions and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1692097T3 true DK1692097T3 (da) | 2009-12-07 |
Family
ID=34486463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04806498T DK1692097T3 (da) | 2003-12-12 | 2004-12-10 | Tricykliske hydroxamat- og benzamidderivater, sammensætninger og fremgangsmåder |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7923579B2 (pt) |
| EP (2) | EP1541549A1 (pt) |
| AT (1) | ATE441628T1 (pt) |
| DE (1) | DE602004022974D1 (pt) |
| DK (1) | DK1692097T3 (pt) |
| ES (1) | ES2330749T3 (pt) |
| PT (1) | PT1692097E (pt) |
| WO (1) | WO2005058803A1 (pt) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030129724A1 (en) | 2000-03-03 | 2003-07-10 | Grozinger Christina M. | Class II human histone deacetylases, and uses related thereto |
| US7154002B1 (en) | 2002-10-08 | 2006-12-26 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| US7250514B1 (en) | 2002-10-21 | 2007-07-31 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| WO2004082638A2 (en) | 2003-03-17 | 2004-09-30 | Syrrx, Inc. | Histone deacetylase inhibitors |
| US20080015190A1 (en) * | 2004-07-12 | 2008-01-17 | Chakravarty Prasun K | Inhibitors of Histone Deacetylase |
| JP2008524246A (ja) | 2004-12-16 | 2008-07-10 | タケダ サン ディエゴ インコーポレイテッド | ヒストンデアセチラーゼ阻害剤 |
| CN101495116A (zh) | 2005-03-22 | 2009-07-29 | 哈佛大学校长及研究员协会 | 蛋白降解病症的治疗 |
| JP2008540574A (ja) | 2005-05-11 | 2008-11-20 | タケダ サン ディエゴ インコーポレイテッド | ヒストンデアセチラーゼ阻害剤 |
| KR20080032188A (ko) | 2005-07-14 | 2008-04-14 | 다케다 샌디에고, 인코포레이티드 | 히스톤 탈아세틸화 효소 억제제 |
| US8796330B2 (en) | 2006-12-19 | 2014-08-05 | Methylgene Inc. | Inhibitors of histone deacetylase and prodrugs thereof |
| AU2007335216C1 (en) * | 2006-12-19 | 2014-07-10 | Methylgene Inc. | Inhibitors of histone deacetylase and prodrugs thereof |
| WO2009018344A1 (en) * | 2007-07-30 | 2009-02-05 | Regents Of The University Of Minnesota | Anticancer agents |
| US20110039937A1 (en) | 2008-02-07 | 2011-02-17 | Abhay Gaitonde | Novel process for the preparation of vorinostat |
| WO2009117808A1 (en) * | 2008-03-25 | 2009-10-01 | Methylgene Inc. | Inhibitors of histone deacetylase |
| JP5665740B2 (ja) | 2008-07-23 | 2015-02-04 | プレジデント アンド フェローズ オブ ハーバード カレッジ | デアセチラーゼ阻害剤およびその使用 |
| WO2010028192A1 (en) | 2008-09-03 | 2010-03-11 | Repligen Corporation | Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors |
| AU2009305214B2 (en) | 2008-10-15 | 2015-06-25 | Generics [Uk] Limited | Process for the preparation of vorinostat |
| CA2744448A1 (en) | 2008-11-26 | 2010-06-03 | Vinayak Gore | Polymorphs |
| WO2011019393A2 (en) | 2009-08-11 | 2011-02-17 | President And Fellows Of Harvard College | Class- and isoform-specific hdac inhibitors and uses thereof |
| WO2011084991A2 (en) * | 2010-01-08 | 2011-07-14 | President And Fellows Of Harvard College | Fluorinated hdac inhibitors and uses thereof |
| WO2012019772A1 (en) * | 2010-08-12 | 2012-02-16 | Institut De Recherche Pour Le Developpement (I.R.D) | Method for treating protozoan parasitic diseases |
| EP2486923B1 (en) * | 2011-02-11 | 2015-09-09 | Dr. Felix Jäger und Dr. Stefan Drinkuth Laborgemeinschaft OHG | Histone deacetylase (HDAC) inhibiting compounds and method of making same |
| US8957066B2 (en) | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| US10059723B2 (en) | 2011-02-28 | 2018-08-28 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| DK2680694T3 (en) | 2011-02-28 | 2019-03-25 | Biomarin Pharm Inc | HISTONDEACETYLASE INHIBITORS |
| CN102329246B (zh) * | 2011-07-04 | 2013-11-20 | 潍坊博创国际生物医药研究院 | 多靶点型他米巴罗汀衍生物、其制备方法和用途 |
| EP2755942A2 (en) | 2011-09-15 | 2014-07-23 | Arizona Board of Regents, a Body Corporate of the State of Arizona acting for and on behalf of Arizona State University | Therapeutic compounds |
| CN103664680A (zh) * | 2012-09-26 | 2014-03-26 | 山东鲁北药业有限公司 | 一种他米巴罗汀合成的新工艺 |
| NZ711585A (en) | 2013-03-15 | 2020-05-29 | Biomarin Pharm Inc | Hdac inhibitors |
| WO2015109318A2 (en) | 2014-01-17 | 2015-07-23 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University | Therapeutic methods |
| US20170114019A1 (en) | 2014-06-04 | 2017-04-27 | Haro Pharmaceutical Inc. | 18-20 member bi-polycyclic compounds |
| CN107304172B (zh) * | 2016-04-20 | 2020-04-03 | 沈阳药科大学 | 八氢蒽类化合物及其制备方法和用途 |
| CN106187818B (zh) * | 2016-06-27 | 2017-12-08 | 刘美新 | 一种制备抗癌药物伏立诺他的方法 |
| US10238655B2 (en) | 2017-01-23 | 2019-03-26 | Arizona Board Of Regents On Behalf Of Arizona State University | Dihydroindene and tetrahydronaphthalene compounds |
| US10238626B2 (en) | 2017-01-23 | 2019-03-26 | Arizona Board Of Regents On Behalf Of Arizona State University | Therapeutic compounds |
| US10231947B2 (en) | 2017-01-23 | 2019-03-19 | Arizona Board Of Regents On Behalf Of Arizona State University | Isochroman compounds and methods of use thereof |
| WO2021158869A1 (en) * | 2020-02-06 | 2021-08-12 | Children's Hospital Medical Center | Compounds, compositions, methods for treating diseases and nerve damage, and methods for preparing compounds |
| CN112479918B (zh) * | 2020-12-11 | 2023-07-14 | 成都大学 | 一种维甲酸类衍生物Am580的合成方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU86351A1 (fr) * | 1986-03-12 | 1987-11-11 | Oreal | Composes benzopyrannyl et benzothiopyrannyl benzoiques,leur procede de preparation et leur utilisation en cosmetique et en medecine humaine et veterinaire |
| DE3903990A1 (de) * | 1989-02-10 | 1990-08-30 | Basf Ag | Phenylhydrazone, ihre herstellung und daraus hergestellte arzneimittel und kosmetika |
| LU87821A1 (fr) * | 1990-10-12 | 1992-05-25 | Cird Galderma | Composes bi-aromatiques,et leur utilisation en medecine humaine et veterinaire et en cosmetique |
| FR2746098B1 (fr) * | 1996-03-14 | 1998-04-30 | Composes propynyl biaromatiques | |
| KR20070053362A (ko) * | 1999-11-23 | 2007-05-23 | 메틸진, 인크. | 히스톤 디아세틸라제의 억제제 |
| US6376548B1 (en) * | 2000-01-28 | 2002-04-23 | Rohm And Haas Company | Enhanced propertied pesticides |
| PE20020354A1 (es) * | 2000-09-01 | 2002-06-12 | Novartis Ag | Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda) |
| EP1401427A4 (en) * | 2001-06-06 | 2004-12-01 | Agouron Pharma | NON-PEPTIDE GNRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF, PROCESSES FOR THE PREPARATION THEREOF |
-
2003
- 2003-12-12 EP EP03293143A patent/EP1541549A1/en not_active Withdrawn
-
2004
- 2004-12-10 ES ES04806498T patent/ES2330749T3/es not_active Expired - Lifetime
- 2004-12-10 AT AT04806498T patent/ATE441628T1/de active
- 2004-12-10 DE DE602004022974T patent/DE602004022974D1/de not_active Expired - Lifetime
- 2004-12-10 US US10/581,947 patent/US7923579B2/en not_active Expired - Fee Related
- 2004-12-10 PT PT04806498T patent/PT1692097E/pt unknown
- 2004-12-10 DK DK04806498T patent/DK1692097T3/da active
- 2004-12-10 WO PCT/IB2004/004334 patent/WO2005058803A1/en active Application Filing
- 2004-12-10 EP EP04806498A patent/EP1692097B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1692097A1 (en) | 2006-08-23 |
| EP1692097B1 (en) | 2009-09-02 |
| DE602004022974D1 (de) | 2009-10-15 |
| PT1692097E (pt) | 2009-10-30 |
| EP1541549A1 (en) | 2005-06-15 |
| WO2005058803A1 (en) | 2005-06-30 |
| US20070129368A1 (en) | 2007-06-07 |
| US7923579B2 (en) | 2011-04-12 |
| ATE441628T1 (de) | 2009-09-15 |
| ES2330749T3 (es) | 2009-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1692097T3 (da) | Tricykliske hydroxamat- og benzamidderivater, sammensætninger og fremgangsmåder | |
| NO20044744L (no) | Karbaminsyreforbindelser omfattende et piperazinledd som HDASinbibitorer | |
| MXPA05011286A (es) | Derivados de acetileno como inhibidores de histona deacetilasa. | |
| MY142589A (en) | Benzimidazole derivatives : preparation and pharmaceutical applications | |
| CY1109363T1 (el) | Υδροξαμικες ενωσεις ως θεραπευτικοι παραγοντες | |
| TW200745047A (en) | Heterocyclic compounds | |
| MY147647A (en) | Imidazo [1,2-a] pyridine derivatives : preparation and pharmaceutical applications | |
| BRPI0411275A (pt) | compostos de carbonila como inibidores de histona deacetilase para tratamento de doenças; composição farmacêutica; método de modular a atividade catalìtica de hdac; método de tratar doença em um indivìduo; utilização de um composto ou composição; método de inibir hdac | |
| WO2007087129A3 (en) | Fluorinated arylamide derivatives | |
| WO2007087130A3 (en) | Hydroxyalkylarylamide derivatives | |
| ATE295725T1 (de) | Valproinsäure und deren derivate als histondeacetylaseinhibitoren | |
| TW200740801A (en) | N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase | |
| WO2007127137A3 (en) | Disubstituted aniline compounds | |
| WO2007002248A3 (en) | Modified malonate derivatives | |
| ATE469897T1 (de) | Indazolcarbonsäureamidverbindungen | |
| BR112022021963A2 (pt) | Inibidores macrocíclicos de peptidilarginina desiminases | |
| CY1109975T1 (el) | Παρα-αλκυλ-υποκατεστημενα αμιδια ν-(4-υδροξυ-3-μεθοξυ-βενζυλο) κιναμμωμικου οξεος και η χρησιμοποιηση τους για την παρασκευη φαρμακων | |
| GB2427405A (en) | Novel hydroxamates as therapeutic agents | |
| HK1125926A1 (en) | Pyrrole derivatives with histone deacetylase inhibitor activity |